Literature DB >> 20172746

Unusual consequences of status epilepticus in Dravet syndrome.

M Chipaux1, N Villeneuve, P Sabouraud, I Desguerre, N Boddaert, C Depienne, C Chiron, O Dulac, R Nabbout.   

Abstract

Although status epilepticus (SE) affects the course of Dravet syndrome (DS), it rarely alters dramatically psychomotor outcome. We report an unusual pattern in 3 patients who following refractory SE lasting respectively 2, 7 and 12h experienced persistent and severe cognitive and motor deterioration. We compared these patients to published data and to personal experience in Necker hospital, to find links between severe outcome and clinical features such as treatment or duration of refractory SE. The key point was that anoxoischemic-like lesions appeared on MRI although cardiovascular function had remained stable. Therefore, neither hemodynamic failure, nor abnormalities of cardiac rhythm could explain the lesions and neurological worsening. For theoretical reasons the responsibility of therapy common for the 3 patients, e.g., barbiturates was suspected. (c) 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20172746     DOI: 10.1016/j.seizure.2010.01.007

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  9 in total

1.  Incidence of Dravet Syndrome in a US Population.

Authors:  Yvonne W Wu; Joseph Sullivan; Sharon S McDaniel; Miriam H Meisler; Eileen M Walsh; Sherian Xu Li; Michael W Kuzniewicz
Journal:  Pediatrics       Date:  2015-10-05       Impact factor: 7.124

Review 2.  Treatment Strategies for Dravet Syndrome.

Authors:  Kelly G Knupp; Elaine C Wirrell
Journal:  CNS Drugs       Date:  2018-04       Impact factor: 5.749

Review 3.  Pharmacotherapy for Dravet Syndrome.

Authors:  Adam Wallace; Elaine Wirrell; Daniel L Kenney-Jung
Journal:  Paediatr Drugs       Date:  2016-06       Impact factor: 3.022

Review 4.  Recent Advances in the Drug Treatment of Dravet Syndrome.

Authors:  Elaine C Wirrell; Rima Nabbout
Journal:  CNS Drugs       Date:  2019-09       Impact factor: 5.749

5.  Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology.

Authors:  Claudia B Catarino; Joan Y W Liu; Ioannis Liagkouras; Vaneesha S Gibbons; Robyn W Labrum; Rachael Ellis; Cathy Woodward; Mary B Davis; Shelagh J Smith; J Helen Cross; Richard E Appleton; Simone C Yendle; Jacinta M McMahon; Susannah T Bellows; Thomas S Jacques; Sameer M Zuberi; Matthias J Koepp; Lillian Martinian; Ingrid E Scheffer; Maria Thom; Sanjay M Sisodiya
Journal:  Brain       Date:  2011-06-29       Impact factor: 13.501

Review 6.  Guidance on Dravet syndrome from infant to adult care: Road map for treatment planning in Europe.

Authors:  Elena Cardenal-Muñoz; Stéphane Auvin; Vicente Villanueva; J Helen Cross; Sameer M Zuberi; Lieven Lagae; José Ángel Aibar
Journal:  Epilepsia Open       Date:  2021-12-19

7.  Neurodevelopmental disorders and anti-epileptic treatment in a patient with a SATB1 mutation: A case report.

Authors:  Ying Yu; Cuiyun Li; Wei Li; Liting Chen; Dan Wang; Jie Wang; Jian Wang; Ruen Yao
Journal:  Front Pediatr       Date:  2022-09-02       Impact factor: 3.569

8.  Encephalopathy in children with Dravet syndrome is not a pure consequence of epilepsy.

Authors:  Rima Nabbout; Nicole Chemaly; Mathilde Chipaux; Giulia Barcia; Charles Bouis; Celia Dubouch; Dorothee Leunen; Isabelle Jambaqué; Olivier Dulac; Georges Dellatolas; Catherine Chiron
Journal:  Orphanet J Rare Dis       Date:  2013-11-13       Impact factor: 4.123

9.  Can the combination of hyperthermia, seizures and ion channel dysfunction cause fatal post-ictal cerebral edema in patients with SCN1A mutations?

Authors:  Carina Büren; Marcel Alexander Kamp; Christopher Munoz-Bendix; Hans-Jakob Steiger; Joachim Windolf; Maxine Dibué-Adjei
Journal:  Epilepsy Behav Case Rep       Date:  2017-12-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.